BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17640177)

  • 1. A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome.
    Dorn SD; Kaptchuk TJ; Park JB; Nguyen LT; Canenguez K; Nam BH; Woods KB; Conboy LA; Stason WB; Lembo AJ
    Neurogastroenterol Motil; 2007 Aug; 19(8):630-7. PubMed ID: 17640177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome.
    Flik CE; Bakker L; Laan W; van Rood YR; Smout AJ; de Wit NJ
    World J Gastroenterol; 2017 Mar; 23(12):2223-2233. PubMed ID: 28405151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The placebo effect in irritable bowel syndrome trials: a meta-analysis.
    Patel SM; Stason WB; Legedza A; Ock SM; Kaptchuk TJ; Conboy L; Canenguez K; Park JK; Kelly E; Jacobson E; Kerr CE; Lembo AJ
    Neurogastroenterol Motil; 2005 Jun; 17(3):332-40. PubMed ID: 15916620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.
    Menees SB; Maneerattannaporn M; Kim HM; Chey WD
    Am J Gastroenterol; 2012 Jan; 107(1):28-35; quiz 36. PubMed ID: 22045120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome.
    Ford AC; Moayyedi P
    Aliment Pharmacol Ther; 2010 Jul; 32(2):144-58. PubMed ID: 20412064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: Complementary and alternative medicine in the irritable bowel syndrome.
    Hussain Z; Quigley EM
    Aliment Pharmacol Ther; 2006 Feb; 23(4):465-71. PubMed ID: 16441466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
    Billings W; Mathur K; Craven HJ; Xu H; Shin A
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1538-1553.e14. PubMed ID: 32961342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture for treatment of irritable bowel syndrome.
    Lim B; Manheimer E; Lao L; Ziea E; Wisniewski J; Liu J; Berman B
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005111. PubMed ID: 17054239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey.
    Larussa T; Rossi M; Suraci E; Marasco R; Imeneo M; Abenavoli L; Luzza F
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781771
    [No Abstract]   [Full Text] [Related]  

  • 11. Complementary and alternative medicine for the irritable bowel syndrome.
    Magge S; Lembo A
    Gastroenterol Clin North Am; 2011 Mar; 40(1):245-53. PubMed ID: 21333910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of irritable bowel syndrome using complementary and alternative medicine.
    Chang FY; Lu CL
    J Chin Med Assoc; 2009 Jun; 72(6):294-300. PubMed ID: 19541564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Bosman M; Elsenbruch S; Corsetti M; Tack J; Simrén M; Winkens B; Boumans T; Masclee A; Keszthelyi D
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):459-473. PubMed ID: 33765447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of use of alternative and complementary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease].
    Carmona-Sánchez R; Tostado-Fernández FA
    Rev Gastroenterol Mex; 2005; 70(4):393-8. PubMed ID: 17058977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome.
    Shapiro JM; Deutsch JK
    Gastroenterol Clin North Am; 2021 Sep; 50(3):671-688. PubMed ID: 34304794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Talley NJ; Schoenfeld PS; Quigley EM; Moayyedi P
    Gut; 2009 Mar; 58(3):367-78. PubMed ID: 19001059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the predictors of the placebo response in irritable bowel syndrome.
    Pitz M; Cheang M; Bernstein CN
    Clin Gastroenterol Hepatol; 2005 Mar; 3(3):237-47. PubMed ID: 15765443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Hawrelak JA; Wohlmuth H; Pattinson M; Myers SP; Goldenberg JZ; Harnett J; Cooley K; Van De Venter C; Reid R; Whitten DL
    Complement Ther Med; 2020 Jan; 48():102233. PubMed ID: 31987249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicines in irritable bowel syndrome: an integrative view.
    Grundmann O; Yoon SL
    World J Gastroenterol; 2014 Jan; 20(2):346-62. PubMed ID: 24574705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine and mind-body therapies for treatment of irritable bowel syndrome in women.
    Magge SS; Wolf JL
    Womens Health (Lond); 2013 Nov; 9(6):557-67. PubMed ID: 24161308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.